T lymphocytes have been implicated in the onset of many autoimmune diseases; however, the mechanism underlying T-cell activation toward self antigens are poorly understood. To study whether T-lymphocyte costimulation can overcome the immunologic unresponsiveness observed in an in Wivo model, we have created tansgenic mice essing the costimulatory mouse molecule B7-1, a lignd for the CD28 receptor, on pancreatic beta cells. We now report that tripletransgenic mice expressing both B7-1 and a viral glycoprotein on their beta cells, along with T cells expressing the viralglycoprotein-speifc ransgenc T-cell receptor, all develop insulitis (ymphocytic infiltration of the pancreatic islets) and diabetes. In striking contrast, the T cells in double-tansgenic mice expressing the same viral glycoprotein (but no B7) on their pancreatic beta cells and the traenic T-cell receptor on their T cells, reported earlier, remain indifferent to the glycoproteinexpressing beta cells. In fact, all three transgenes are required to initiate immune-mediated destruction of the beta cells. Mice expressing any of the transgenes alone, or any two in combination, maintain normal islet architecture and never spontaneously develop insulitis or diabetes. Our results show that aberrant B7 expression on peripheral tissues may play an important role in the activation of self-reactive T cells and further suggest that abnormal expression of costimulatory receptors may be involved in various T-cell-mediated autoimmune diseases.
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T-lymphocyte activation in vitro requires two signals: the first is generated by the T-cell receptor (TCR)/CD3 complex after engagement with nominal antigen presented in the context of major histocompatibility complex proteins. De- livery ofthis first signal, however, is not sufficient to activate T cells in vitro (1, 2). The second or "costimulatory" signal necessary for T-cell activation is generated when other T-lymphocyte receptors most importantly CD28, interact with appropriate counter-receptors (3) (4) (5) (6) . Moreover, recent studies have suggested that these two signals are required for optimal T-lymphocyte activation to particular antigens in vivo (7) (8) (9) (10) (11) .
The counter-receptor for CD28 is B7. B7, now recognized to be a family of receptors, is expressed on specialized antigen-presenting cells (APC) that express both major histocompatibility complex class I and H molecules. For example, B7-1 expression has been documented on activated B (12, 13) and T (14) lymphocytes, y interferon-treated monocytes (15) , and constitutively on macrophages (16) , dendritic cells (17) , and on fetal or neonatal thymic epithelial cells (18, 19) . The more recently reported B7-2 receptor (20) (21) (22) , also called B70 (23) Until now, the ability of such aberrant B7 expression to induce an autoimmune reaction has not been tested experimentally. To study this, we used the recently described double-transgenic mice expressing both the lymphocytic choriomeningitis virus glycoprotein (GP) on pancreatic beta cells, and a transgenic TCR specific for GP peptide- (33) (34) (35) (36) (37) (38) (39) (40) (41) in the context of H-2Db (26) . Approximately 80% of the mature CD8+ T cells in these animals are potentially selfreactive, and yet the animals never develop either a pancreatic islet lymphocytic infiltrate ("insulitis") or diabetes spontaneously. Therefore, the presence of self-reactive T cells alone seems insufficient to induce a destructive autoimmune reaction. We have asked whether coexpression ofB7-1 on the pancreatic beta cells can abrogate the tolerant status in these mice and lead to the immune destruction of their pancreatic beta cells. As Typing of transgenic animals. DNA was isolated from tail biopsies by using described proteinase K methods (30, 31) . In some cases the B7-1 transgene was detected by standard genomic Southern technique: the DNA was cut with EcoRI, subjected to gel electrophoresis, transferred to Nytran (Schleicher & Schuell), and then probed with a 722-bp Pst I fragment of the rat 1 insulin promoter-B7-1 DNA construct. The transgenes for GP, the TCR a chain, and in some cases B7-1 were detected by PCR. The primer pairs used were as follows: for GP, 5'-CAAGCAAGATGTAGAGTCTGCG and 5'-GGCTT-TGGACATGAACCGCCC; for TCR a chain, 5'-CGAG-GATCCTTTAACTGGTACACAGCAGG and 5'-CT-GACCTGCAGTTATGAGGACAGCAC;andforB7-1, 5'-CA-AACAACAGCCTTACCTTCGG and 5'-GCCTCCAAAA-CCTACACATCCT.
Breeding. The B7-1 transgenic mice (H-2q) were crossed with mice (H-2b) transgenic for either or both the GP or TCR transgenes. The cross resulted in some mice expressing both GP and mouse B7-1 on pancreatic beta cells (B7-GP double transgenics, H-2bxq) and other mice expressing B7-1 on their beta cells and the transgenic TCR on their T lymphocytes (B7-TCR double transgenics, H-2bxq). With further breeding we obtained mice that carried all three transgenes-i.e., the GP-B7-TCR triple-transgenic mice. In all cases, the pair bred to create the triple-transgenic mice included one member homozygous for H-2b to insure that the offspring would carry the H-2b haplotype necessary for GP presentation to the transgenic TCR T cells. The three following breeding pairs were used: GP-TCR (H-2b) x B7 (H-2q), B7-GP (H-2bxq) x TCR (H-2b), and B7-TCR (H-2bxq) x GP-TCR (H-2b).
Immunohistochemistry. Peptide hormones. Pancreata were fixed in 10%1 formalin and embedded in paraffin. Sections were then cut, treated with trypsin for 15 min (for insulin staining), and stained with the insulin-specific mAb 3 monoclonal antibody (32) at a 1:30,000 dilution. By using the protein A-gold technique (33), a color reaction was developed. Adjacent tissue sections were stained with hematoxylin/eosin.
Cell-surface receptor staining. Pancreata were snapfrozen in liquid nitrogen, and 5-pm-thick cryostat sections were cut and fixed in acetone for 10 min. These sections were then incubated with the primary antibodies YTS169.4.2 (anti-CD8) (34), YTS191.1 (anti-CD4) (34), F4/80 (anti-macrophage) (35) , anti-B220, or biotinylated hamster anti-mouse B7-1 (16) obtained from Repligen. For B7-1 staining, sections were preincubated with 1% bovine serum albumin and then washed with phosphate-buffered saline before the 60-min, room temperature reaction with the anti-B7-1 antibody. The sections were then treated with ExtrAvidin-horseradish peroxidase (Sigma) for 60 min, and the color was developed by incubating with 0.1% diaminobenzidine/0.03% H202 for 15-20 min. For other than B7-1 surface staining, the primary antibodies were followed by a two-step indirect immunoenzymatic staining procedure. Goat Histologic analysis of double (GP-TCR and B7-GP) and triple (GP-B7-TCR) transgenic mice. Photos are paired and are stained as follows: Hematoxylin/eosin (Left) and antiinsulin antibodies (Right). Sections from GP-TCR animals (A and B) and from B7-GP animals (C and D) reveal normal islet architecture, no lymphocytic infiltrate, and normal immunostaining for insulin. Sections from prediabetic (E and F) and diabetic (G and H) tripletransgenic mice reveal an intense lymphocytic infiltrate and a loss (F) or absence (H) of islet cells staining for insulin.
Proc. Natl. Acad. Sci. USA 91 (1994) 3139 (Fig. 2 A and B) and the B7-GP (Fig. 2 C and D) doubletransgenic mice revealed normal islet architecture, no evidence for insulitis, and normal immunohistochemical staining for insulin. On the other hand, pancreatic sections from a 10-week-old, not yet diabetic, GP-B7-TCR mouse revealed an ongoing insulitis with a diminished, but still present, mass of beta cells (Fig. 2 E and F) . Moreover, pancreatic sections taken from a 10-week-old, diabetic triple-transgenic mouse and stained with antiinsulin or antiglucagon antibodies revealed the presence of alpha cells in the islet-cell remnants (P.A. and H.H., data not shown), but the total absence of insulin-producing beta cells (Fig. 2H) . The onset of hyperglycemia in the triple-transgenic mice was followed by ketosis, wasting, and ultimately a fatal outcome consistent with the histologic evidence for complete beta-cell destruction.
Analysis ofIslet Infltrating Cell Phenotype. To examine the phenotype of the islet-infiltrating cells, pancreatic sections Proc. Nat!. Acad. Sci. USA 91 (1994) from a 9-week-old euglycemic GP-TCR mouse and from two triple-transgenic mice, one 4 weeks old and not yet diabetic and one 9 weeks old and diabetic, were subjected to additional immunohistologic analysis (Fig. 3) . These studies revealed few, if any, immune cells in the pancreas of the GP-TCR mouse (Fig. 3 A, D, G, and J) . Alternatively, the sections from the 4-week-old GP-B7-TCR mouse demonstrated a mixture of a few, faintly stained CD8+ and CD4+ T lymphocytes (Fig. 3 B and E, respectively) and an increased number of macrophages (Fig. 3H) surrounding the pancreatic islets. Sections taken from the diabetic triple-transgenic mouse revealed a severe insulitis and periinsulitis with CD8+ and CD4+ T lymphocytes, macrophages (Fig. 3 C, F, and I , respectively), and B lymphocytes (Fig. 3L) infiltrating the islets.
Response of Transgenic Mice to Infection with GPExp g Recombinant Vaccinia. To further evaluate the absence of spontaneous diabetes in double-and singletransgenic mice, their response to infection with a recombinant vaccinia virus expressing GP (vacc-GP) was studied. Interestingly, all four of the B7-GP double-transgenic mice infected with 2 x 106 plaque-forming units of vacc-GP developed diabetes 6-10 days after infection. Three B7 and 15 GP single-transgenic and 2 B7-TCR double-transgenic mice were similarly infected with vacc-GP: none developed diabetes; however, pancreatic sections from the infected GP mice did reveal a mild insulitis as reported (31) . The present result suggests that the susceptibility of B7-GP mice to vacc-GP-induced diabetes is due to beta-cell B7-1 expression, supporting a self-perpetuating destructive autoimmune process. The resistance of GP transgenic mice to vacc-GPinduced diabetes has been noted (31) and may be attributable to the lack of costimulatory ligand on their beta cells. Because vacc-GP infection did not lead to diabetes in the GP, B7, or B7-TCR mice, the response was not a nonspecific sequela of the viral infection. These vacc-GP infection data also indicate that GP-specific T lymphocytes are not clonally deleted in the B7-GP mice. The observation that B7-GP mice never spontaneously develop diabetes suggests the importance of the antigen-specific T-cell precursor frequency in this model. Lymphocyte TCR and Functional Assays. In view of the disparate outcomes observed in the GP-TCR double-transgenic and the GP-B7-TCR triple-transgenic mice, studies to determine their T-lymphocyte cell-surface receptor and functional status were performed. For both the GP-TCR doubletransgenic and the GP-B7-TCR triple-transgenic mice, -480% of CD8+ lymph node T lymphocytes stained with antibodies specific for the transgenic TCR (P.A. and H.H., data not shown). These data are consistent with similar analysis previously reported for the GP-TCR double-transgenic mice (26) and reflect the skewing of the T-cell repertoire toward CD8+ cells driven by the positive selection of T cells expressing the transgenic TCR. The functional capacity of the T lymphocytes from the double-and triple-transgenic mice was measured in a CTL assay. Fig. 4 shows that CTLs derived from the double-and triple-transgenic mice were equally able to lyse target cells presenting the appropriate GP epitope. This result demonstrates that the self-reactive T cells could be activated in vitro and, therefore, are not impaired in their effector function. Thus, no evidence for T-cell anergy was detected to explain the absence of pancreatic beta-cell killing in the GP-TCR mice (26 The absence of spontaneous diabetes in the B7-GP doubletransgenic mice, despite the presence of GP-specific T cells demonstrated by our vacc-GP data, also warrants further comment. It is now well recognized that naive T cells normally do not circulate through nonlymphoid tissues (39) . Therefore, the infrequent GP-specific T cells in these mice most likely never encounter the beta cells expressing both cognate antigen and the costimulatory ligand. If this is the case, then what accounts for the spontaneous diabetes in the triple-transgenic mice because our data suggests that the peripheral T cellsfrom those mice are naive as well? We are considering two potential explanations. (i) While the circulation ofnaive T cells through nonlymphoid tissues is not a common event, it may nevertheless occur rarely. Because the majority of the T cells in triple-transgenic mice are specific for the GP on the beta cell, such a rare event could result in T-cell activation via the B7-1 costimulatory molecule on the beta cells. (ii) An alternative explanation is that bispecific T cells, as recently described (40) (41) (42) , may play a role. In this scenario, T cells expressing two distinct TCRs are cross-activated by environmental antigens via the endogenously rearranged TCR, migrate to the pancreas, and cause beta-cell destruction via their GP-specific transgenic TCR. If such T cells bearing two TCRs are playing a role in our model, then since only GP-B7-TCR mice devel-3140 immunology: Harlan et A oped diabetes spontaneously (GP-TCR never did), these results suggests that the B7-1 on the beta cells must promote an inflammatory process in vivo necessary for the beta-cell killing.
Our results suggest that the regulated absence of B7 or B7-like receptors on the surface of most nonlymphoid cells may be a normal mechanism for the maintenance of T-cell tolerance in the periphery. Furthermore, our data illustrate that the aberrant expression of B7 or B7-like molecules on peripheral tissue cells, as has been found in the naturally occurring disease states of Graves disease (24) and psoriasis (25) , can result in a breakdown of T-cell unresponsiveness and lead to destructive autoimmune processes.
